Skip to content

Stonepine Capital Management, LLC

Follow

13F filer, CIK 1440771, Bend, OR

Stonepine Capital Management, LLC reported $159,374,182 across 78 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 64.52% of the portfolio.

Accepted , ingested 13F-HR 0001440771-26-000027

Period
2026-09-30
Reported value
$159M
Holdings
78
Top 10 weight
64.52%
New
25
Sold out
34

Part of the filer group Stonepine Capital Management, LLC

  • Jon M. Plexico
  • Stonepine GP, LLC
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CAMPadded+1,396,627$5.64M
RAREadded+185,000$2.78M
BSXnew+55,000$2.4M
PYXSnew+689,000$1.61M
SRZNnew+44,100$1.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EOLSreduced-618,540-$4.95M
VSTMreduced-306,852-$2.47M
CRBPreduced-330,000-$2.25M
TELAexited-2,662,427-$2M
ZVRAreduced-158,701-$1.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001440771-26-000027, largest first. % of portfolio is the value over $119,774,182, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 870,000 shares; 2025Q1: 613,000 shares; 2025Q2: 1,360,386 shares; 2025Q3: 2,670,032 shares; 2025Q4: 2,732,079 shares; 2026Q1: 3,302,300 shares; 2026Q2: 3,349,627 shares; 2026Q3: 3,042,775 shares 3,042,775$24.5M20.45%-306,852Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 228,894 shares; 2026Q1: 1,389,622 shares; 2026Q2: 1,389,622 shares; 2026Q3: 2,786,249 shares 2,786,249$11.3M9.4%+1,396,627Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,264,651 shares; 2025Q1: 1,134,574 shares; 2025Q2: 916,500 shares; 2025Q3: 1,536,391 shares; 2025Q4: 1,631,588 shares; 2026Q1: 1,759,091 shares; 2026Q2: 1,590,162 shares; 2026Q3: 971,622 shares 971,622$7.77M6.49%-618,540Timeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,241,032 shares; 2025Q1: 810,000 shares; 2025Q2: 750,000 shares; 2025Q3: 739,000 shares; 2025Q4: 740,000 shares; 2026Q1: 740,000 shares; 2026Q2: 740,000 shares; 2026Q3: 700,000 shares 700,000$7.02M5.86%-40,000Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,200 shares; 2025Q3: 85,000 shares; 2025Q4: 85,000 shares; 2026Q1: 85,000 shares; 2026Q2: 120,654 shares; 2026Q3: 110,000 shares 110,000$6.66M5.56%-10,654Timeline
ELOXELOXX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 397,160 shares; 2026Q3: 381,977 shares 381,977$5.85M4.88%-15,183Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 491,624 shares; 2026Q3: 455,058 shares 455,058$3.87M3.23%-36,566Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,359 shares; 2026Q1: 345,179 shares; 2026Q2: 345,179 shares; 2026Q3: 377,429 shares 377,429$3.62M3.02%+32,250Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$3.58M2.99%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,000 shares; 2026Q3: 210,000 shares 210,000$3.16M2.64%+185,000Timeline
EDSAEDESA BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 687,500 shares; 2025Q2: not reported; 2025Q3: 687,500 shares; 2025Q4: 687,500 shares; 2026Q1: 30,000 shares; 2026Q2: 456,439 shares; 2026Q3: 710,266 shares 710,266$2.99M2.5%+253,827Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000$2.4M2%newTimeline
AYTUAYTU BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 407,549 shares; 2025Q1: 463,721 shares; 2025Q2: 812,676 shares; 2025Q3: 891,855 shares; 2025Q4: 813,704 shares; 2026Q1: 792,289 shares; 2026Q2: 912,921 shares; 2026Q3: 964,900 shares 964,900$2.06M1.72%+51,979Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 196,732 shares; 2025Q1: not reported; 2025Q2: 544,494 shares; 2025Q3: 563,913 shares; 2025Q4: 627,668 shares; 2026Q1: 713,845 shares; 2026Q2: 551,692 shares; 2026Q3: 350,877 shares 350,877$1.87M1.56%-200,815Timeline
XLOXILIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 64,162 shares; 2026Q2: 225,994 shares; 2026Q3: 189,092 shares 189,092$1.71M1.43%-36,902Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 689,000 shares 689,000$1.61M1.34%newTimeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: 450,970 shares; 2025Q4: 709,505 shares; 2026Q1: 746,587 shares; 2026Q2: 557,284 shares; 2026Q3: 282,016 shares 282,016$1.48M1.24%-275,268Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 137,200 shares; 2025Q1: 285,782 shares; 2025Q2: 306,029 shares; 2025Q3: 250,146 shares; 2025Q4: 113,631 shares; 2026Q1: 33,005 shares; 2026Q2: not reported; 2026Q3: 44,100 shares 44,100$1.42M1.18%newTimeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,550 shares; 2026Q3: 749,028 shares 749,028$1.38M1.15%+644,478Timeline
KTTAPASITHEA THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 275,062 shares; 2026Q1: 831,301 shares; 2026Q2: 2,201,468 shares; 2026Q3: 2,774,234 shares 2,774,234$1.37M1.14%+572,766Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 220,011 shares; 2026Q1: 221,955 shares; 2026Q2: 245,518 shares; 2026Q3: 188,201 shares 188,201$1.34M1.12%-57,317Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,132,388 shares; 2025Q1: 914,973 shares; 2025Q2: 733,793 shares; 2025Q3: 735,019 shares; 2025Q4: 2,348,147 shares; 2026Q1: 957,202 shares; 2026Q2: 396,179 shares; 2026Q3: 647,285 shares 647,285$1.33M1.11%+251,106Timeline
OKYOOKYO PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 850,000 shares; 2026Q2: 862,996 shares; 2026Q3: 914,367 shares 914,367$1.18M0.98%+51,371Timeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 78,189 shares; 2026Q1: 53,460 shares; 2026Q2: 199,486 shares; 2026Q3: 252,434 shares 252,434$1.15M0.96%+52,948Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,884 shares; 2026Q1: 975,200 shares; 2026Q2: 660,000 shares; 2026Q3: 588,000 shares 588,000$1.11M0.93%-72,000Timeline
ZVRAZEVRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 597,700 shares; 2025Q1: 650,000 shares; 2025Q2: 775,620 shares; 2025Q3: 810,000 shares; 2025Q4: 569,088 shares; 2026Q1: 480,000 shares; 2026Q2: 258,701 shares; 2026Q3: 100,000 shares 100,000$1.1M0.92%-158,701Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 171,100 shares; 2026Q1: 50,000 shares; 2026Q2: 917,100 shares; 2026Q3: 520,000 shares 520,000$998K0.83%-397,100Timeline
CDXSCODEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 88,264 shares; 2025Q4: 256,106 shares; 2026Q1: 417,994 shares; 2026Q2: 109,662 shares; 2026Q3: 676,973 shares 676,973$941K0.79%+567,311Timeline
INABIN8BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 82,430 shares; 2025Q3: 159,421 shares; 2025Q4: 164,893 shares; 2026Q1: 663,412 shares; 2026Q2: 695,287 shares; 2026Q3: 697,852 shares 697,852$928K0.77%+2,565Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 63,039 shares 63,039$747K0.62%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$744K0.62%newTimeline
AZTRAZITRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,285,476 shares; 2026Q3: 5,227,438 shares 5,227,438$719K0.6%-58,038Timeline
FEMYFEMASYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 326,770 shares 326,770$706K0.59%newTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 60,000 shares; 2025Q2: 109,010 shares; 2025Q3: 453,800 shares; 2025Q4: 463,700 shares; 2026Q1: 269,100 shares; 2026Q2: 161,583 shares; 2026Q3: 254,759 shares 254,759$706K0.59%+93,176Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 60,000 shares 60,000$702K0.59%+10,000Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 35,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 389,916 shares; 2026Q1: 383,462 shares; 2026Q2: 425,000 shares; 2026Q3: 95,000 shares 95,000$648K0.54%-330,000Timeline
AEONAEON BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,125,748 shares 2,125,748$638K0.53%newTimeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 349,615 shares; 2025Q3: 300,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 85,000 shares 85,000$628K0.52%newTimeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 125,000 shares; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 205,000 shares; 2026Q3: 220,000 shares 220,000$598K0.5%+15,000Timeline
SINTSINTX TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 209,205 shares; 2026Q3: 233,936 shares 233,936$522K0.44%+24,731Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,998 shares 18,998$500K0.42%newTimeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 68,688 shares; 2026Q2: 100,718 shares; 2026Q3: 98,147 shares 98,147$475K0.4%-2,571Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: not reported; 2026Q3: 787,269 shares 787,269$469K0.39%newTimeline
CALCCALCIMEDICA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 278,680 shares 278,680$451K0.38%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 289,237 shares; 2025Q4: 230,050 shares; 2026Q1: 224,650 shares; 2026Q2: 230,538 shares; 2026Q3: 414,903 shares 414,903$448K0.37%+184,365Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 132,578 shares; 2026Q2: 130,684 shares; 2026Q3: 162,818 shares 162,818$444K0.37%+32,134Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,056,338 shares; 2025Q4: 593,573 shares; 2026Q1: 335,309 shares; 2026Q2: 224,989 shares; 2026Q3: 150,000 shares 150,000$435K0.36%-74,989Timeline
NGENNERVGEN PHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 271,678 shares; 2026Q3: 200,000 shares 200,000$382K0.32%-71,678Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 43,491 shares; 2026Q3: 40,000 shares 40,000$364K0.3%-3,491Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 73,271 shares; 2026Q3: 88,108 shares 88,108$279K0.23%+14,837Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 57,663 shares 57,663$264K0.22%newTimeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 31,200 shares 31,200$258K0.22%newTimeline
QTIQT IMAGING HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$254K0.21%0Timeline
MXCTMAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 459,018 shares; 2025Q4: 469,018 shares; 2026Q1: 1,004,673 shares; 2026Q2: 751,606 shares; 2026Q3: 224,881 shares 224,881$252K0.21%-526,725Timeline
CNSPCNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 48,827 shares; 2026Q1: 61,000 shares; 2026Q2: 41,573 shares; 2026Q3: 39,942 shares 39,942$212K0.18%-1,631Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 145,900 shares; 2025Q3: 670,000 shares; 2025Q4: 486,400 shares; 2026Q1: 768,288 shares; 2026Q2: 815,436 shares; 2026Q3: 110,479 shares 110,479$211K0.18%-704,957Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000$180K0.15%newTimeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 555,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 51,000 shares 51,000$174K0.15%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$153K0.13%newTimeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 106,175 shares; 2025Q3: 413,453 shares; 2025Q4: 710,071 shares; 2026Q1: 597,682 shares; 2026Q2: 154,595 shares; 2026Q3: 52,547 shares 52,547$132K0.11%-102,048Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 116,147 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$115K0.1%newTimeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,400 shares; 2026Q2: 30,122 shares; 2026Q3: 33,842 shares 33,842$97.8K0.08%+3,720Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 50,000 shares; 2025Q2: 151,085 shares; 2025Q3: 188,571 shares; 2025Q4: 45,000 shares; 2026Q1: 50,000 shares; 2026Q2: 20,000 shares; 2026Q3: 11,948 shares 11,948$84.7K0.07%-8,052Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 310,000 shares; 2026Q2: 364,254 shares; 2026Q3: 49,468 shares 49,468$54.4K0.05%-314,786Timeline
EVAXEVAXION ASQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 19,713 shares; 2026Q2: 17,562 shares; 2026Q3: 16,566 shares 16,566$54.3K0.05%-996Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 500,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,600,000 shares; 2025Q4: 805,800 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$24.6K0.02%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
INSMINSMED INC Stockcall40,000$5.6M0
ADMAADMA BIOLOGICS INC COMcall400,000$5.2M-250,000
EOLSEVOLUS INC COMcall500,000$5M+80,000
ZLABZAI LAB LTD ADRcall150,000$4.5Mnew
ESTAESTABLISHMENT LABS HLDGS INC COMMON STOCKcall50,000$4.25Mnew
MIRMMIRUM PHARMACEUTICALS INC COMcall40,000$4.2Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMcall100,000$3M-100,000
ALMSALUMIS INC COMcall200,000$2.6Mnew
ARDXARDELYX INC COMcall300,000$1.5M+150,000
ABEOABEONA THERAPEUTICS INC COM NEWcall200,000$1.4Mnew
PHATPHATHOM PHARMACEUTICALS INC COMMON STOCKcall100,000$1.25Mnew
ZVRAZEVRA THERAPEUTICS INC Stockcall100,000$1.1Mnew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MDTMEDTRONIC PLC50,000$4.38Mcall
ABTABBOTT LABORATORIES40,000$3.8Mcall
BSXBOSTON SCIENTIFIC CORP50,000$3.25Mcall
BMRNBIOMARIN PHARMACEUTICAL INC50,000$3.12Mcall
XERSXERIS BIOPHARMA HOLDINGS INC280,000$2.1Mcall
TELATELA BIO INC2,662,427$2Mshares
CRISCURIS INC3,312,185$1.73Mshares
SPRBSPRUCE BIOSCIENCES INC28,795$1.55Mshares
HRTXHERON THERAPEUTICS INC1,000,000$1.5Mcall
SIBNSI BONE INC100,000$1.5Mcall
NMRANEUMORA THERAPEUTICS INC.500,000$1.25Mcall
SLGLSOL-GEL TECHNOLOGIES LTD14,469$1.07Mshares
DCTHDELCATH SYS INC100,000$1Mcall
PHATPHATHOM PHARMACEUTICALS INC85,010$922Kshares
HELPCYBIN INC129,280$855Kshares
MNKDMANNKIND CORP250,000$750Kcall
NVCTNUVECTIS PHARMA INC40,000$736Kshares
CBIOCRESCENT BIOPHARMA INC.40,000$720Kshares
PMVPPMV PHARMACEUTICALS INC536,086$718Kshares
ORKAORUKA THERAPEUTICS INC7,500$714Kshares
RADXRADIOPHARM THERANOSTICS LTD51,000,000$670Kshares
CALCCALCIMEDICA INC622,432$545Kshares
ARVNARVINAS INC60,000$499Kshares
ANLADLAI NORTYE GROUP LTD24,257$279Kshares
SENSSENSEONICS HLDGS INC48,680$277Kshares
POCIPRECISION OPTICS CORP INC MA46,390$237Kshares
UPBUPSTREAM BIO INC33,432$231Kshares
RNTXREIN THERAPEUTICS INC218,038$227Kshares
HRTXHERON THERAPEUTICS INC490,787$209Kshares
HUMAHUMACYTE INC231,299$181Kshares
PCSAPROCESSA PHARMACEUTICALS INC55,000$106Kshares
BCABBIOATLA INC16,432$68Kshares
CGENCOMPUGEN LTD31,387$67.2Kshares
OVIDOVID THERAPEUTICS INC21,300$57.3Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001440771-26-000027 base2026-11-13